India’s Traditional Knowledge Digital Library (TKDL), which has a database containing formatted information on more than 2 million medicinal formulations is proving a powerful weapon in the country’s fight against erroneous patents. Discuss the pros and cons of making this database publicly available under open-source licensing.
Set out the arguments for and against making TKDL openly available under an open-source licence, with examples, and reach a balanced judgement.
Common trap: Many answers simply praise TKDL. The question is about one policy choice: open-source release. A top answer explains why TKDL is currently restricted, notes that open access could aid biopiracy and weaken benefit-sharing, and proposes a calibrated access model.
SyllabusAwareness in the fields of IT, Space, Computers, robotics, nano-technology, bio-technology and issues relating to intellectual property rights.
Model answer
12.5 marks · 200-word limitThe Traditional Knowledge Digital Library, set up in 2001 by CSIR and the department dealing with Indian systems of medicine, transcribes Ayurveda, Unani, Siddha and Yoga formulations into English, French, German, Japanese and Spanish so that patent examiners can recognise them as prior art.
- Classical texts in Sanskrit, Arabic, Persian, Urdu, Tamil
- Formulations coded and translated into five languages
- Patent offices search TKDL under non-disclosure
- Claim shown to lack novelty
- Application withdrawn or rejected
Why the question arises
- Restricted access today: Since the EPO agreement of February 2009 and USPTO and UK agreements of January 2010, patent offices consult TKDL under non-disclosure agreements, and CSIR files evidence against wrongful applications.
- Past battles: Costly challenges to the turmeric patent at the USPTO (revoked 1997) and the neem patent at the EPO (revoked 2000) showed the need for searchable prior art.
Pros of open-source availability
- Global prior art: Every patent office, including those without agreements, and every third party could cite TKDL to oppose bad patents.
- Research and industry: Indian AYUSH firms, universities and start-ups could build on validated formulations, aiding drug discovery.
- Transparency and preservation: Open data allows peer scrutiny, correction and wider use of a national heritage.
Cons of open-source availability
- A blueprint for biopiracy: Firms could use the formulations to develop modified derivatives that may still be patentable as inventive improvements.
- Loss of benefit-sharing leverage: An open licence permits free commercial use, undercutting access and benefit-sharing under the Biological Diversity Act, 2002 and the Nagoya Protocol, in force since October 2014.
- Community rights: Knowledge holders such as vaidyas and tribal healers lose control and reward, and open publication cannot be undone.
Balanced approach
- Tiered access: Keep full formulations restricted, but open summary search to researchers and Indian industry under licences that require prior informed consent and benefit-sharing.
- Domestic safeguards: Combine TKDL with Section 3(p) of the Patents Act, 1970, which excludes traditional knowledge from patentability, and People's Biodiversity Registers.
TKDL works because it is a shield, not a free warehouse. India should widen access in a controlled, benefit-linked way while pressing at the WTO and WIPO for mandatory disclosure of origin, so that traditional knowledge is protected and its holders rewarded.
Read more — sources
- OfficialCSIR — Traditional Knowledge Digital Library (tkdl.res.in), About TKDL
- NCERTBiology (Class XII) — Ch. 10, Biotechnology and its Applications (biopiracy section)
- OfficialThe Patents Act, 1970 (as amended in 2002) — Section 3(p) (India Code)
- OfficialThe Biological Diversity Act, 2002 and the Nagoya Protocol on Access and Benefit-sharing (CBD)
Related questions from earlier years
More from GS Paper 3 2015
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.